Runmed Medical is a developer of vascular interventional surgery robots, currently focusing on the design, development and commercialization of coronary angiography fractional flow reserve (caFFR) systems and coronary angiography microvascular resistance index (caIMR) systems. Runmed Medical is independent innovation and aggressive, and gradually weaves a global R&D, production, sales and service network. Listed in Hong Kong today. It opened 10.26% lower at HK$5.6 and fell nearly 20% during the session. As of press time, the decline narrowed to 9.78% at HK$5.63, with the latest market value of HK$6.572 billion. According to the results of the previous IPO placement, Runmed-B was offered at HK$6.24 per share, with 1,000 shares per lot, and 23.348 million shares were issued globally, of which 2.336 million were offered in Hong Kong and 21.012 million were offered internationally.
This article is reproduced from: https://www.itjuzi.com/investevent/13331469
This site is for inclusion only, and the copyright belongs to the original author.